Prompted by the clinical observation in daily practice that some male AIH patients harboring the PNPLA3 risk allele presented with adverse clinical outcomes and slow treatment response, we conducted a detailed investigation of all our AIH patients. The gene discussed is PNPLA3; the disease is autoimmune hepatitis.